Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sadler

Showing results (181-190 of 256) with videos related to

Pageof 26
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1986
Primary malignant tumours of the trigeminal nerveF B Maroun, M Sadler, G P Murray, et al.
Pharmacotherapy|November 1, 1994
Prolonged, but not diminished, zidovudine absorption induced by a high-fat breakfastM J Shelton, A Portmore, M R Blum, et al.
Journal of Clinical Pharmacology|February 8, 2018
Oliceridine (TRV130), a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic ModelMichael J Fossler, Brian M Sadler, Colm Farrell, et al.
CNS Drugs|June 10, 2017
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic ModelMarjie L Hard, Richard J Mills, Brian M Sadler, et al.
Journal of Cell Science|April 19, 2000
The amino- and carboxyl-terminal tails of (beta)-catenin reduce its affinity for desmoglein 2Wahl JK3rd, J E Nieset, P A Sacco-Bubulya, et al.
Journal of Clinical Pharmacology|February 3, 2018
Oliceridine, a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. II: Simulation of Potential Phase 3 Study Designs Using a Pharmacokinetic/Pharmacodynamic ModelMichael J Fossler, Brian M Sadler, Colm Farrell, et al.
Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|November 12, 2013
Interpreting principal components in biomechanics: representative extremes and single component reconstructionScott C E Brandon, Ryan B Graham, Sivan Almosnino, et al.
British Journal of Clinical Pharmacology|March 31, 2015
Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patientsJianping Zhang, Siobhán Hayes, Brian M Sadler, et al.
Proceedings. Biological Sciences|July 10, 2015
When and how did the terrestrial mid-Permian mass extinction occur? Evidence from the tetrapod record of the Karoo Basin, South AfricaMichael O Day, Jahandar Ramezani, Samuel A Bowring, et al.
Transplantation|January 11, 2018
Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular CarcinomaErin M Sadler, Neil Mehta, Mamatha Bhat, et al.
Pageof 26

Showing results (181-190 of 256) with videos related to

Sort By:
Pageof 26
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1986
Primary malignant tumours of the trigeminal nerveF B Maroun, M Sadler, G P Murray, et al.
Pharmacotherapy|November 1, 1994
Prolonged, but not diminished, zidovudine absorption induced by a high-fat breakfastM J Shelton, A Portmore, M R Blum, et al.
Journal of Clinical Pharmacology|February 8, 2018
Oliceridine (TRV130), a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic ModelMichael J Fossler, Brian M Sadler, Colm Farrell, et al.
CNS Drugs|June 10, 2017
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic ModelMarjie L Hard, Richard J Mills, Brian M Sadler, et al.
Journal of Cell Science|April 19, 2000
The amino- and carboxyl-terminal tails of (beta)-catenin reduce its affinity for desmoglein 2Wahl JK3rd, J E Nieset, P A Sacco-Bubulya, et al.
Journal of Clinical Pharmacology|February 3, 2018
Oliceridine, a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. II: Simulation of Potential Phase 3 Study Designs Using a Pharmacokinetic/Pharmacodynamic ModelMichael J Fossler, Brian M Sadler, Colm Farrell, et al.
Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|November 12, 2013
Interpreting principal components in biomechanics: representative extremes and single component reconstructionScott C E Brandon, Ryan B Graham, Sivan Almosnino, et al.
British Journal of Clinical Pharmacology|March 31, 2015
Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patientsJianping Zhang, Siobhán Hayes, Brian M Sadler, et al.
Proceedings. Biological Sciences|July 10, 2015
When and how did the terrestrial mid-Permian mass extinction occur? Evidence from the tetrapod record of the Karoo Basin, South AfricaMichael O Day, Jahandar Ramezani, Samuel A Bowring, et al.
Transplantation|January 11, 2018
Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular CarcinomaErin M Sadler, Neil Mehta, Mamatha Bhat, et al.
Pageof 26